Errata for
Ranjan, Mol Vis 2006;
12:1077-1085.
The changes below were made to the article on the date noted. These changes have been incorporated in the article and the details are documented here.
5 October 2006:
These changes consist of correcting typographical errors in the use of "m (milli)" and "μ" in several places in the text. The changes in the sentences below are identified in red.
In the Methods section, under the side heading "Production and characterization of polyclonal antibodies to crystallins (β- and γ-crystallin) and glycated crystallins (β-gly- and γ-gly-crystallin)" the ninth sentence was corrected from:
A primer dose of 250-300 mg/kg of body mass of the purified crystallins (β- and γ-crystallin) and synthesized glycated crystallins (β-gly- and γ-gly-crystallin) were injected at multiple sites (intradermal injection).
to:
A primer dose of 250-300 μg/kg of body mass of the purified crystallins (β- and γ-crystallin) and synthesized glycated crystallins (β-gly- and γ-gly-crystallin) were injected at multiple sites (intradermal injection).
In the Methods section, under the side heading "Production and characterization of polyclonal antibodies to crystallins (β- and γ-crystallin) and glycated crystallins (β-gly- and γ-gly-crystallin)" the 11th sentence was corrected from:
Later, three booster doses were given (100-150 mg/kg) intramuscularly in Freund's incomplete adjuvant.
to:
Later, three booster doses were given (100-150 μg/kg) intramuscularly in Freund's incomplete adjuvant.
In the Methods section, under the side heading "Noncompetitive ELISA", first paragraph, the second sentence was corrected from:
Briefly, a 96 well microtiter plate was coated with a concentration of antigens (β-, γ-crystallins, 500 ng/50 ml/well and β-gly-, γ-gly-crystallins, 100 ng/50 ml/well) dissolved in 0.1 M carbonate buffer, pH 9.6, overnight at 37 °C and washed thrice with washing buffer (phosphate buffer saline [PBS-T] 0.01 M, pH 7.2 with 0.05% tween-20 and 0.01% sodium azide).
to:
Briefly, a 96 well microtiter plate was coated with a concentration of antigens (β-, γ-crystallins, 500 ng/50 μl/well and β-gly-, γ-gly-crystallins, 100 ng/50 μl/well) dissolved in 0.1 M carbonate buffer, pH 9.6, overnight at 37 °C and washed thrice with washing buffer (phosphate buffer saline [PBS-T] 0.01 M, pH 7.2 with 0.05% tween-20 and 0.01% sodium azide).
In the Methods section, under the side heading "Noncompetitive ELISA", first paragraph, the third sentence was corrected from:
The wells were blocked for nonspecific binding with 100 ml/well of 0.1% fish gelatin in PBS (0.01 M, pH 7.2) and washed three times as earlier.
to:
The wells were blocked for nonspecific binding with 100 μl/well of 0.1% fish gelatin in PBS (0.01 M, pH 7.2) and washed three times as earlier.
In the Methods section, under the side heading "Noncompetitive ELISA", first paragraph, the sixth sentence was corrected from:
The plates were washed thrice and 150 μl/well of substrate (450 μl of TMB [10 μg/ml of dimethyl sulfoxide] in 15 μl of 0.1 M acetate buffer pH 5.0 containing 0.25% (w/v) β-cyclodextrin and 0.015% (w/v) of urea hydrogen peroxide) was added.
to:
The plates were washed thrice and 150 μl/well of substrate (450 μl of TMB [10 mg/ml of dimethyl sulfoxide] in 15 ml of 0.1 M acetate buffer pH 5.0 containing 0.25% (w/v) β-cyclodextrin and 0.015% (w/v) of urea hydrogen peroxide) was added.
In the Methods section, under the side heading "Antibody capture assay", the sixth sentence was corrected from:
The plates were washed thrice and 150 μl/well of substrate (450 μl of TMB [10 μg/ml of dimethyl sulfoxide]) in 15 μl of 0.1 M acetate buffer pH 5.0 containing 0.25% (w/v) β-cyclodextrin and 0.015% (w/v) of urea hydrogen peroxide was added.
to:
The plates were washed thrice and 150 μl/well of substrate (450 μl of TMB [10 mg/ml of dimethyl sulfoxide]) in 15 ml of 0.1 M acetate buffer pH 5.0 containing 0.25% (w/v) β-cyclodextrin and 0.015% (w/v) of urea hydrogen peroxide was added.